![Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-4226264-1-150x150.jpg "Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI 12")
Medical Cannabis for Autoimmune Pain Management According to Dr. Caplan
Patients with autoimmune conditions are increasingly turning to medical cannabis for autoimmune pain when traditional therapies prove insufficient. Dr. Caplan's clinical experience shows cannabis can provide meaningful adjunctive relief, though evidence…
Cannabinoid formulation patent describes improved controlled-release profile #6
A patent filing describes a controlled-release cannabinoid composition with potential therapeutic applications.
Cannabinoids in Mental Health Treatment: Efficacy and Safety Evidence
Clinical Takeaway Randomized controlled trial evidence for cannabinoids as a primary treatment for mental health conditions and substance use disorders remains limited and inconclusive. Clinicians should not assume efficacy or safety based on approval…
Cancer Survivors Report Little Direct Cannabis Stigma—But Opioid Stigma Looms Large in Pain Decisions
Many CS discussed the presence of opioid-related stigma, both perceived from society and internalized, which appeared to play an important role in their symptom-management decision-making.
Cannabinoid Clinical Trials: Mental Health Evidence
Clinical Takeaway Clinical Takeaway: Current randomized controlled trial evidence does not demonstrate established efficacy or safety of cannabinoids as primary treatment for mental disorders or substance use disorders. Existing research gaps mean…
CBD Gummies and Increased Libidos: What the Evidence Actually Shows
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Sexual HealthCbdEvidence-Based…
Can CBD gummies cause psychosis? – Pathologica
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CbdMental HealthPsychosisProduct…
Cannabinoid Clinical Trials: EEG Sleep Insomnia RCT
Clinical Takeaway In this small pilot trial of 20 insomnia patients, a single oral dose of 10 mg THC combined with 200 mg CBD reduced total sleep time compared to placebo, suggesting that this cannabinoid combination did not improve and may have worsened…
IBS Clinical Care Gaps and the Potential of Future Therapeutics based on Peripheral Visceral Afferent Modulation.
Current management of irritable bowel syndrome (IBS) is focused on bowel dysfunction or central neuromodulators. Aims of this review were to: appraise unmet ...
World’s largest cart and battery!
When your patient asks if there's a higher-capacity option, remind them that bigger hardware doesn't necessarily mean better pharmacokinetics. The real question is whether they're treating symptoms or just collecting peripherals. Via…